世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2014年
25期
7-8,10
,共3页
鼻窦癌%CD24%预后指标
鼻竇癌%CD24%預後指標
비두암%CD24%예후지표
paranasal sinus carcionma%CD24%prognosis marker
目的:检测CD24蛋白在鼻窦癌组织中表达的情况,探讨其与临床病理参数的关系及对鼻窦癌预后的临床意义。方法应用免疫组织化学方法检测26例鼻窦癌组织中CD24的表达情况并分析CD24与鼻窦癌临床病理特征及预后的关系。结果 CD24在鼻窦癌组织中的阳性表达率明显高于癌旁组织。CD24在鼻窦癌的阳性表达与患者的年龄、性别、肿瘤分型、组织学分级无关,而与淋巴结转移、临床分期正相关;CD24是影响鼻窦癌预后的独立预后因素。结论CD24表达可能提示鼻窦癌发展的恶性进程,其高表达提示鼻窦癌患者预后不良,有望成为一个新的相对独立的鼻窦癌患者生存的预后指标。
目的:檢測CD24蛋白在鼻竇癌組織中錶達的情況,探討其與臨床病理參數的關繫及對鼻竇癌預後的臨床意義。方法應用免疫組織化學方法檢測26例鼻竇癌組織中CD24的錶達情況併分析CD24與鼻竇癌臨床病理特徵及預後的關繫。結果 CD24在鼻竇癌組織中的暘性錶達率明顯高于癌徬組織。CD24在鼻竇癌的暘性錶達與患者的年齡、性彆、腫瘤分型、組織學分級無關,而與淋巴結轉移、臨床分期正相關;CD24是影響鼻竇癌預後的獨立預後因素。結論CD24錶達可能提示鼻竇癌髮展的噁性進程,其高錶達提示鼻竇癌患者預後不良,有望成為一箇新的相對獨立的鼻竇癌患者生存的預後指標。
목적:검측CD24단백재비두암조직중표체적정황,탐토기여림상병리삼수적관계급대비두암예후적림상의의。방법응용면역조직화학방법검측26례비두암조직중CD24적표체정황병분석CD24여비두암림상병리특정급예후적관계。결과 CD24재비두암조직중적양성표체솔명현고우암방조직。CD24재비두암적양성표체여환자적년령、성별、종류분형、조직학분급무관,이여림파결전이、림상분기정상관;CD24시영향비두암예후적독립예후인소。결론CD24표체가능제시비두암발전적악성진정,기고표체제시비두암환자예후불량,유망성위일개신적상대독립적비두암환자생존적예후지표。
ObjectiveTo study the significance of CD24 protein expressions in human paranasal sinus carcinoma and their relationship with clinical pathological parameters and clinical prognosis.Methods The expressions of CD24 protein were studied in 26 paranasal sinus carcinoma samples by Elivision immunohistochemical (IHC) analysis and the relationships of CD24 with clinical pathological parameters and prognosis were also explored.Results The expression of CD24 in paranasal sinus carcinoma was signiifcantly higher than that in adjacent normal tissues. The expression of CD24 was not related with the age of patient, sexuality, tumor type, histologic grade, but there was a positive correlation with the lymphnode metastasis and the clinical stage of tumor and CD24 was an independent prognostic factor for paranasal sinus carcinoma prognosis.Conclusion CD24 may be related to the malignant process of paranasal sinus carcinoma. Over expression of CD24 indicates poor prognosis in paranasal sinus carcinoma patients. CD24 may become a new prognostic marker for paranasal sinus carcinoma.